KRT20 and neoplasm: Moreover, half of the patients with CK20-negative bone marrow samples had died after 37 months (43 months: tumor-specific survival), while half of the patients with CK20-positive samples had already died after 27 months (also tumor-specific survival) (Figure 2C,D).